New Zealanders Can Now Access Funded OPDIVO® (Nivolumab) For Previously Treated Metastatic Renal Cell Carcinoma 0 02.11.2024 08:33 Scoop This OPDIVO funding marks the first kidney cancer medicine decision following the New Zealand Government’s funding boost announced June 2024. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
